Advertisement

Topics

10 years later, Shire gains FDA approval for ADHD drug

05:16 EDT 21 Jun 2017 | Pharmafile

Shire has revealed that the FDA has approved its long-acting and interestingly named ADHD drug, Mydayis. The approval comes more than 10 years from the first time that the drug was submitted to the FDA in 2006. After a series of set-backs, the company has now filed sufficient data for the approval of the drug.

read more

Original Article: 10 years later, Shire gains FDA approval for ADHD drug

NEXT ARTICLE

More From BioPortfolio on "10 years later, Shire gains FDA approval for ADHD drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Attention deficit hyperactivity disorder (ADHD)
Attention deficit hyperactivity disorder (ADHD) is a group of behavioural symptoms that include inattentiveness, hyperactivity and impulsiveness. Attention deficit disorder (ADD) is a sub-type of ADHD - symptoms of ADHD include: a short attenti...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...